Free Trial
NASDAQ:MLEC

Moolec Science (MLEC) Stock Price, News & Analysis

Moolec Science logo
$9.09 +0.07 (+0.82%)
Closing price 05/23/2025 03:58 PM Eastern
Extended Trading
$8.61 -0.48 (-5.32%)
As of 05/23/2025 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Moolec Science Stock (NASDAQ:MLEC)

Key Stats

Today's Range
$8.89
$8.90
50-Day Range
$5.60
$9.30
52-Week Range
$5.30
$12.60
Volume
1,038 shs
Average Volume
4,005 shs
Market Capitalization
$36.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

Receive MLEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Moolec Science and its competitors with MarketBeat's FREE daily newsletter.

MLEC Stock News Headlines

Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
Moolec Science Appeals Nasdaq Delisting Notice
See More Headlines

MLEC Stock Analysis - Frequently Asked Questions

Moolec Science's stock was trading at $8.00 at the beginning of the year. Since then, MLEC stock has increased by 13.7% and is now trading at $9.0940.
View the best growth stocks for 2025 here
.

Moolec Science SA (NASDAQ:MLEC) posted its quarterly earnings data on Wednesday, April, 16th. The company reported ($0.60) EPS for the quarter, hitting analysts' consensus estimates of ($0.60). The firm earned $2.64 million during the quarter, compared to analysts' expectations of $2.01 million. Moolec Science had a negative net margin of 140.32% and a negative trailing twelve-month return on equity of 119.34%.

Moolec Science shares reverse split before market open on Wednesday, May 14th 2025. The 1-10 reverse split was announced on Tuesday, April 29th 2025. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 13th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Moolec Science investors own include PayPal (PYPL), TriNet Group (TNET), Tesla (TSLA), ABM Industries (ABM), Adverum Biotechnologies (ADVM), APi Group (APG) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
4/16/2025
Today
5/25/2025
Next Earnings (Estimated)
5/29/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Holding & other investment offices
Sub-Industry
Trading
Current Symbol
NASDAQ:MLEC
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,310,000.00
Net Margins
-140.32%
Pretax Margin
-148.60%

Debt

Sales & Book Value

Annual Sales
$7.83 million
Price / Cash Flow
N/A
Book Value
$0.18 per share
Price / Book
50.52

Miscellaneous

Free Float
30,791,000
Market Cap
$36.49 million
Optionable
Not Optionable
Beta
-0.39
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:MLEC) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners